clinical trial manager new york

Stocks2Watch to Host Investor Luncheon with Special Guest, Bruce Campbell from StoneCastle Investment Management, Tuesday November 30th

Stocks2Watch Investor Series today announced their agenda is set for the Investor Luncheon with Special Guest, Bruce Campbell from StoneCastle Investment Management, Tuesday November 30. Individual investors, institutional investors, advisors, and analysts are invited to register now to attend the Luncheon.

REGISTER NOW AT: https://app.livestorm.co/stocks2watch/investor-luncheon-nov-30

Gain market insight, find investment opportunities, and consider investing in StoneCastle's various funds… all safely in the comfort of your office/home using our latest technology. Confirmed Investor & Finance Professionals will receive a gift certificate to order in lunch on Tuesday, November 30.

LUNCHEON AGENDA: (Eastern Time)

12:00PM: Market Outlook - Bruce Campbell, Portfolio Manager at StoneCastle
12:20PM: Quipt Home Medical (Healthcare) TSX.V: QIPT
12:40PM: PlantFuel Life (Life Science) CSE: FUEL
1:00PM: Levitee Labs (Healthcare) CSE: LVT
1:20PM: New "Stocks2Watch" Picks by Bruce Campbell, Portfolio Manager at StoneCastle

Registration Open to Investors and Finance Professionals >>> This event is suitable for private investors, brokers, fund managers, financial institutions, funds, buy & sell side analysts, influencers, newsletter writers and journalists. The event is not suitable for people pursuing commercial opportunities.

REGISTER NOW AT: https://app.livestorm.co/stocks2watch/investor-luncheon-nov-30

ABOUT STOCKS2WATCH:

Stocks2Watch hosts online and in-person interactive events for publicly-traded companies to meet and present directly with investors. To learn more about Stocks2Watch and view a complete list of events, please visit www.stocks2watch.ca

NEXT LUNCHEON: Scheduled for Thursday January 20th

CONTACT:

Neil Lock,
info@stocks2watch.ca
604-410-4888

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/104215

News Provided by Newsfile via QuoteMedia

The Conversation (0)
Levitee Labs

Levitee Labs

Transforming the Traditional Landscape of Mental Health, Addiction Treatment and Pain Management Treatment Across Multiple Verticals

Transforming the Traditional Landscape of Mental Health, Addiction Treatment and Pain Management Treatment Across Multiple Verticals Keep Reading...
A pill bottle with US flag and coloured pills.

Medical Cannabis and Psychedelics Reforms Reshaping Mental Health Markets

The landscape for medical cannabis and psychedelic therapies has rapidly shifted in just a few weeks following recent executive actions in the US. Between the formal rescheduling of medical cannabis to Schedule III and an executive order aimed at accelerating mental health treatments, several... Keep Reading...
Dried mushrooms in the center are surrounded by translucent capsules on a white background.

Executive Order Sparks New Phase for Psychedelic Biotech, Risks Remain

On April 18, President Trump was joined by top health officials in the Oval Office to sign Accelerating Medical Treatments For Serious Mental Illness, an executive order to expand research into ibogaine. This signals the strongest federal endorsement yet of psychedelic medicine as an alternative... Keep Reading...
Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies

Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies

Company's clinical research operations and therapist training programs directly positioned to support accelerated research and commercialization timelinesNuminus Wellness Inc. (OTC: NUMIF) today acknowledged the Executive Order signed by President Donald J. Trump directing United States federal... Keep Reading...
Emyria Limited

Emyria Launches Global Services Platform Targeting International Drug Sponsors

Emyria’s established, world-first, unique national clinical delivery network to drive a new services-led revenue stream focused on global drug sponsors.

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”), a leader in innovative mental health treatments, is pleased to announce the launch of its Empax Global Partnership Program, a new services platform enabling international drug sponsors to access Emyria’s established clinical delivery... Keep Reading...
Numinus Wellness Provides Update Regarding Listing Status

Numinus Wellness Provides Update Regarding Listing Status

Numinus Wellness Inc. (TSX: NUMI) (OTC Pink: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with an emphasis on safe, evidence-based psychedelic-assisted therapies, is providing an update regarding its listing status on the... Keep Reading...
Numinus Wellness Provides Corporate Update

Numinus Wellness Provides Corporate Update

Numinus Wellness Inc. (TSX: NUMI) (OTC: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is providing a corporate update.Corporate UpdateOver the past year,... Keep Reading...

Interactive Chart

Latest Press Releases

Related News